Skip to main content
. 2020 Jan 29;29:e96. doi: 10.1017/S2045796020000049

Table 3.

HRs for diabetes complications and mortality of the diabetes patients with and without depressive disorder, total and stratified by types of depression, gender, age and duration between diagnosis and initiation of pharmacotherapy

Macro complication
aHR (95% CI)
Micro complication
aHR (95% CI)
DM-related death
aHR (95% CI)
Circulation death
aHR (95% CI)
Unnatural death
aHR (95% CI)
Suicide
aHR (95% CI)
All-cause mortality
aHR (95% CI)
All samples 1.35 (1.32–1.37) 0.99 (0.97–1.02) 0.86 (0.77–0.95) 0.96 (0.88–1.06) 2.59 (2.30–2.91) 5.64 (4.70–6.77) 1.08 (1.04–1.12)
Types of depression
MDD, recurrent 1.44 (1.39–1.50) 1.04 (0.99–1.09) 1.08 (0.87–1.33) 1.07 (0.88–1.30) 4.52 (3.64–5.63) 12.00 (8.31–17.31) 1.19 (1.11–1.28)
MDD, single 1.38 (1.31–1.45) 1.01 (0.95–1.07) 0.99 (0.75–1.30) 1.07 (0.85–1.35) 3.10 (2.31–4.16) 6.90 (4.43–10.73) 1.18 (1.09–1.28)
Dysthymia 1.31 (1.27–1.35) 0.97 (0.93–1.00) 0.71 (0.61–0.84) 0.91 (0.79–1.04) 1.89 (1.58–2.27) 3.26 (2.49–4.27) 1.01 (0.96–1.06)
Depressive disorder, NOS 1.25 (1.17–1.34) 0.97 (0.90–1.05) 0.92 (0.66–1.29) 0.85 (0.63–1.15) 1.29 (0.82–2.02) 4.80 (2.31–9.94) 1.03 (0.92–1.14)
Sex
Male 1.30 (1.26–1.34) 0.99 (0.96–1.03) 0.87 (0.75–1.02) 0.94 (0.82–1.07) 2.24 (1.92–2.62) 4.76 (3.77–6.00) 1.06 (1.01–1.11)
Female 1.38 (1.34–1.42) 0.99 (0.96–1.02) 0.85 (0.73–0.99) 1.00 (0.87–1.14) 3.23 (2.67–3.90) 7.38 (5.48–9.95) 1.11 (1.06–1.17)
Sex × depression interaction p-Value = 0.0017 p-Value = 0.9997 p-Value = 0.7069 p-Value = 0.4888 p-Value = 0.0015 p-Value = 0.0118 p-Value = 0.1745
Age
20–44 1.51 (1.44–1.59) 1.06 (1.01–1.11) 1.22 (0.92–1.61) 1.34 (1.00–1.81) 4.00 (3.15–5.08) 8.92 (6.19–12.85) 1.35 (1.23–1.48)
45–64 1.35 (1.31–1.39) 0.98 (0.95–1.01) 0.83 (0.70–0.99) 0.92 (0.78–1.08) 2.75 (2.33–3.25) 5.29 (4.13–6.79) 1.09 (1.03–1.15)
65 1.24 (1.19–1.29) 0.96 (0.91–1.01) 0.76 (0.64–0.90) 0.93 (0.81–1.05) 1.35 (1.04–1.76) 3.33 (2.20–5.05) 0.97 (0.92–1.02)
Age × depression interaction
(45–64 v. 20–44)
(65 v. 20–44)
p-Value <0.0001
p-Value <0.0001
p-Value = 0.0003
p-Value = 0.0005
p-Value = 0.0002
p-Value <0.0001
p-Value = 0.0181
p-Value = 0.0079
p-Value = 0.0017
p-Value <0.0001
p-Value = 0.0070
p-Value = 0.0003
p-Value <0.0001
p-Value <0.0001
Duration between diagnosis and initiation of pharmacotherapy
<1 year 1.34 (1.31–1.37) 0.97 (0.95–1.00) 0.81 (0.72–0.92) 0.92 (0.83–1.03) 0.92 (0.83–1.03) 5.45 (4.48–6.62) 1.05 (1.01–1.09)
≧1 year 1.36 (1.30–1.42) 1.06 (1.01–1.12) 1.07 (0.84–1.36) 1.16 (0.94–1.45) 1.16 (0.94–1.45) 7.06 (4.22–11.79) 1.20 (1.11–1.29)
Duration × depression interaction p-Value = 0.7812 p-Value = 0.0013 p-Value = 0.0218 p-Value = 0.0839 p-Value = 0.5794 p-Value = 0.4134 p-Value = 0.0046

MDD, major depressive disorder; NOS, not otherwise specified.